Home LiteratureArticle Details
PMID: 6742813 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.

Antimicrobial agents and chemotherapy ·Vol. 25 ·No. 6 ·1984-06-00 ·Pages 683-6

Levison ME, Kobasa WD

Abstract

The efficacies of mezlocillin and ticarcillin, each alone and in combination with gentamicin, in the therapy of experimental left-sided Enterobacter aerogenes endocarditis in rabbits were compared. Each beta-lactam was administered intramuscularly at a dose of 180 mg/kg every 6 h either alone or with gentamicin (1.7 mg/kg intramuscularly every 8 h). Bacterial populations at the start of therapy (7 days after initiation of infection) were 9 to 10 log10 CFU/g of vegetation. Ticarcillin produced concentrations in serum that were twice those produced by mezlocillin, but the therapeutic ratios of mezlocillin and ticarcillin (ratio of peak level in serum to MBC) were the same. All of the therapeutic regimens given for either 5 or 10 days were effective in reducing vegetation counts when compared with the untreated controls (P less than 0.01 for all comparisons), except mezlocillin alone and ticarcillin alone, which caused insignificant reductions in counts after 5 days of therapy (P greater than 0.05). After 10 days of therapy, the only regimen that was significantly different from another was that of mezlocillin plus gentamicin, which was significantly better than that of ticarcillin alone (P less than 0.01). These studies document that mezlocillin and ticarcillin were both effective in reducing the numbers of E. aerogenes CFU in vegetations in rabbits with experimental endocarditis when the drugs were given over a prolonged course. More rapid and extensive reduction in vegetation counts was achieved with combinations of an aminoglycoside plus mezlocillin or ticarcillin. Mortality was significantly less among rabbits treated with mezlocillin plus gentamicin.

MeSH Terms
Animals Drug Therapy, Combination Endocarditis, Bacterial/blood,drug therapy Enterobacter Enterobacteriaceae Infections/drug therapy Female Gentamicins/blood,therapeutic use Half-Life Mezlocillin/blood,therapeutic use Microbial Sensitivity Tests Penicillins/therapeutic use Rabbits Ticarcillin/blood,therapeutic use
Chemicals
Gentamicins Penicillins Ticarcillin Mezlocillin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Levison M E
Kobasa W D
References (6)
6 references, click to expand
  1. Pharmacology of cefazolin in patients with normal and abnormal renal function.
    J Infect Dis. 1973 Oct;128:Suppl:S354-7 PMID: 4744017
  2. Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin.
    J Infect Dis. 1977 Sep;136(3):327-35 PMID: 903671
  3. Pharmacokinetics of mezlocillin in healthy volunteers.
    Antimicrob Agents Chemother. 1978 Dec;14(6):801-6 PMID: 742869
  4. Cefoperazone treatment of experimental endocarditis.
    Antimicrob Agents Chemother. 1981 May;19(5):773-6 PMID: 6457556
  5. The penicillins.
    Mayo Clin Proc. 1983 Jan;58(1):21-32 PMID: 6218348
  6. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa.
    Rev Infect Dis. 1983 Mar-Apr;5(2):314-21 PMID: 6405476
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1984-06-00
Pages
683-6
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC185622
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com